$TCON News Article - TRACON Pharmaceuticals Announces Dosing of First Patient in Phase 1/2 Trial of YH001 in Combination with Envafolimab and Doxorubicin in Front Line Sarcoma https://marketwirenews.com/news-releases/trac...11889.html
(0)
(0)
TRACON Pharmaceuticals Inc. (TCON) Stock Research Links